Skip to main content
ImmuneCited

Multiple sclerosis.

Alan Gaby
Review Global advances in health and medicine 2013 19 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D24381825'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
Patients with multiple sclerosis
Intervention
Multiple sclerosis. None
Vergleichsgruppe
None
Primärer Endpunkt
Multiple sclerosis management overview
Wirkungsrichtung
Neutral
Verzerrungsrisiko
Unclear

Abstract

Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system. Common manifestations include paresthesias, diplopia, loss of vision, numbness or weakness of the limbs, bowel or bladder dysfunction, spasticity, ataxia, fatigue, and mental changes. Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapsing. The cause of MS is unknown, although it appears to be an autoimmune disease. Much of what is known about MS has been learned from an animal model of the disease, experimental allergic encephalomyelitis.

Zusammenfassung

Four main patterns of MS are recognized: relapsing remitting, primary progressive, secondary progressive, and progressive relapse, which is an autoimmune disease.

Used In Evidence Reviews

Similar Papers